Beta-blocking agents in the treatment of hypertension.
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000328:Adult; D000367:Age Factors; D000553:Ambulatory Care; D001794:Blood Pressure / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010869:Pindolol / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D012083:Renin / Q000097:blood; D012504:Saralasin / Q000494:pharmacology; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D011433:Propranolol; D010869:Pindolol; D012083:Renin; D012504:Saralasin